» Articles » PMID: 30361393

ADAR1-mediated RNA Editing is Required for Thymic Self-tolerance and Inhibition of Autoimmunity

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2018 Oct 27
PMID 30361393
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

T cells play a crucial role in the adaptive immune system, and their maturation process is tightly regulated. Adenosine deaminase acting on RNA 1 (ADAR1) is the enzyme responsible for adenosine-to-inosine RNA editing in dsRNAs, and loss of ADAR1 activates the innate immune sensing response via melanoma differentiation-associated protein 5 (MDA5), which interprets unedited dsRNA as non-self. Although ADAR1 is highly expressed in the thymus, its role in the adaptive immune system, especially in T cells, remains elusive. Here, we demonstrate that T cell-specific deletion of in mice causes abnormal thymic T cell maturation including impaired negative selection and autoimmunity such as spontaneous colitis. This is caused by excessive expression of interferon-stimulated genes, which reduces T cell receptor (TCR) signal transduction, due to a failure of RNA editing in ADAR1-deficient thymocytes. Intriguingly, concurrent deletion of MDA5 restores thymocyte maturation and prevents colitis. These findings suggest that prevention of MDA5 sensing of endogenous dsRNA by ADAR1-mediated RNA editing is required for preventing both innate immune responses and T cell-mediated autoimmunity.

Citing Articles

Writers, readers, and erasers RNA modifications and drug resistance in cancer.

Chen D, Gu X, Nurzat Y, Xu L, Li X, Wu L Mol Cancer. 2024; 23(1):178.

PMID: 39215288 PMC: 11363509. DOI: 10.1186/s12943-024-02089-6.


RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection.

Huang M, Mark A, Pham J, Vera K, Saravia-Butler A, Beheshti A PLoS One. 2024; 19(8):e0307450.

PMID: 39178184 PMC: 11343423. DOI: 10.1371/journal.pone.0307450.


Role of RNA modifications in blood development and regeneration.

Gunage R, Zon L Exp Hematol. 2024; 138:104279.

PMID: 39009277 PMC: 11415282. DOI: 10.1016/j.exphem.2024.104279.


Navigating the landscape of epitranscriptomics and host immunity.

Huang E, Frydman C, Xiao X Genome Res. 2024; 34(4):515-529.

PMID: 38702197 PMC: 11146601. DOI: 10.1101/gr.278412.123.


Do RNA modifications contribute to modulation of immune responses in allergic diseases?.

Kudrin P, Rebane A Front Allergy. 2023; 4:1277244.

PMID: 38026133 PMC: 10679440. DOI: 10.3389/falgy.2023.1277244.


References
1.
Crow Y, Chase D, Lowenstein Schmidt J, Szynkiewicz M, Forte G, Gornall H . Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A. 2015; 167A(2):296-312. PMC: 4382202. DOI: 10.1002/ajmg.a.36887. View

2.
Otero D, Baker D, David M . IRF7-dependent IFN-β production in response to RANKL promotes medullary thymic epithelial cell development. J Immunol. 2013; 190(7):3289-98. PMC: 3608802. DOI: 10.4049/jimmunol.1203086. View

3.
Stetson D, Ko J, Heidmann T, Medzhitov R . Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008; 134(4):587-98. PMC: 2626626. DOI: 10.1016/j.cell.2008.06.032. View

4.
Nishikura K . Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010; 79:321-49. PMC: 2953425. DOI: 10.1146/annurev-biochem-060208-105251. View

5.
Jeon S, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H . Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog. 2012; 8(5):e1002714. PMC: 3364948. DOI: 10.1371/journal.ppat.1002714. View